India  

Govt sees Covaxin efficacy as validation of its scientific process

IndiaTimes Friday, 5 March 2021
The phase 3 results of Covaxin released on Wednesday showing 81% efficacy is seen by the government as a major validation of the scientific process and regulatory decision making while granting emergency use authorisation that helped in achieving a timely rollout of the nationwide vaccination programme on January 16.
0
shares
ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

Government Government System or group of people governing an organized community, often a state

Govt claims contrary to reality: Chidambaram

Congress leader P. Chidambaram on Sunday lashed out at the government for making claims 'contrary to the reality' in the country.
IndiaTimes

Govt denies it is planning to scale back rapid COVID testing amid concerns over false positives

The government has denied it is planning to scale back rapid coronavirus testing after reports claimed senior officials are concerned about false positives.
Sky News
MP queries lack of BSL interpreter at Downing Street press conferences [Video]

MP queries lack of BSL interpreter at Downing Street press conferences

Labour MP Vicky Foxcroft (Lewisham Deptford) signed her question to the Prime Minister, asking about sign language interpretation on Government press conferences.Then speaking her question, she asked: “If the Prime Minister doesn’t understand, imagine how those who rely on British Sign Language feel at his press briefings.“£2.6 million spent on the new press room, yet still no interpreter.“What message does he think this sends to disabled people?”Boris Johnson responded: “I’m grateful to the honourable lady and grateful for the way she has set out her question.“I will revert to her as soon as I can.”

Credit: PA - Press Association STUDIO    Duration: 00:45Published
Section 144 in Maharashtra: What's open, what's not [Video]

Section 144 in Maharashtra: What's open, what's not

As India continues to fight second wave of COIVD-19, Maharashtra has remained as the worst-hit state. State Government imposed section 144 for 15 days from April 14 8pm onwards. Public transport will remain operational for emergency services. Maharashtra reported 60,212 fresh COVID infections in last 24 hours.

Credit: ANI    Duration: 02:13Published

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

You Might Like


Related news from verified sources

Covishield or Covaxin: Mutant strains in some West Bengal patients raise concerns over vaccine efficacy

The detection of double mutant Covid strain in some Bengal patients has left experts and those waiting to get vaccinated worried about the efficacy of...
IndiaTimes

Covaxin out of clinical trial mode, granted restricted emergency use authorisation

The Centre on Thursday said Bharat Biotech's indigenously developed Covaxin is out of the "clinical trial mode" and that it has now been granted the regular...
IndiaTimes

'Powerful example for all Indians': Bharat Biotech after PM Modi takes Covaxin shot

Prime Minister Narendra Modi on Monday (March 1) was administered the first dose of COVID-19 vaccine, Covaxin at the AIIMS, Delhi.
DNA